Slide 5

Investigation 9 Biotechnology

Department of Health and Human Services

Public Health Service
Food and Drug Administration

10903 New Hampshire Avenue
Silver Spring, MD 20993



Mr. YC Lei
General Manager
EPS Biotechnology Corp.
No. 8 R&D RD.III
Hsinchu Science Park
Hsinchu, Taiwan 30077

Dear Mr. YC Lei:

During an inspection of your firm located in Hsinchi City, Taiwan, on June 18, 2012, through June 21, 2012, an investigator from the United States Food and Drug Administration (FDA) determined that your firm manufactures glucose dehydrogenase glucose meters. Under section 201(h) of the Federal Food, Drug, and Cosmetic Act (the Act), 21 U.S.C. § 321(h), these products are devices because they are intended for use in the diagnosis of disease or other conditions or in the cure, mitigation, treatment, or prevention of disease, or to affect the structure or function of the body.

This inspection revealed that these devices are adulterated within the meaning of section 501(h) of the Act, 21 U.S.C. § 351(h), in that the methods used in, or the facilities or controls used for, their manufacture, packing, storage, or installation are not in conformity with the current good manufacturing practice requirements of the Quality System regulation found at Title 21, Code of Federal Regulations (CFR), Part 820. We received a response from you, dated July 10, 2012, concerning our investigator’s observations noted on the Form FDA 483 (FDA 483), List of Inspectional Observations, which was issued to your firm. We address this response below, in relation to each of the noted violations. These violations include, but are not limited to, the following:

1. Failure to establish and maintain adequate procedures for receiving, reviewing, and evaluating complaints by a formally designated unit, as required by 21 CFR 820.198(a).

Interesting facts
Aldon Corporation Innovating Science IS3709 AP Biology Investigation #9 - Biotechnology: Restriction Enzyme Analysis of DNA
BISS (Aldon Corporation)
  • Students will perform the electrophoresis process on DNA samples treated with different restriction enzymes and construct a standard curve using a known DNA sample
  • While performing the process they will also determine the approximate size of the DNA fragments in the unknown samples
  • Materials provided for eight lab groups
  • Meets AP Science Practices 3 and 6, and Big Idea 3
Coordinated framework for regulation of biotechnology : hearing before the Subcommittee on Investigations and Oversight and the Subcommittee on Natural Resources, Agriculture Research, and Environment and the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, House of Representatives, Ninety-ninth Congress, second session, July 23, 1986.
Book (U.S. G.P.O.For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.)
Related Posts